Tradewinds Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Tradewinds Capital Management's UTHR Position: Q2 2026 in Review
Tradewinds Capital Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 32 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.
Tradewinds Capital Management first reported a position in UTHR in Q1 2020 and has held it in 26 quarters since. The position peaked at $19K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Tradewinds Capital Management held 32 shares of United Therapeutics worth $17.3K as of Q2 2026.
- Tradewinds Capital Management left its United Therapeutics share count unchanged in Q2 2026.
- United Therapeutics made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #335 holding.
- Tradewinds Capital Management first reported a position in United Therapeutics in Q1 2020 and has held it in 26 quarters since.
- Tradewinds Capital Management's United Therapeutics position peaked at $19K in Q1 2026.
- 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.